Akero Therapeutics, Inc.
AKRO
Revenue
0.00
0.000.00%
-Assets
825.89M
▲8.34M▲1.02%
3 Months ChangeLiabilities
75.77M
▼-3.45M▼-4.35%
3 Months ChangeFree Cash Flow
-70.95M
▼-70.95M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 10-Q
ID: 0000950170-24-094347
2024-08-09
Form 8-K
ID: 0001193125-24-197477
2024-06-12
Form 8-K
ID: 0001193125-24-160069
2024-05-10
Form 10-Q
ID: 0000950170-24-057458
2024-05-10
Form 8-K
ID: 0001193125-24-135733
2024-03-18
Form 8-K
ID: 0001193125-24-070191
2024-03-06
Form 8-K
ID: 0001193125-24-060883
2024-03-04
Form 8-K
ID: 0001193125-24-056901
2024-02-29
Form 8-K
ID: 0001193125-24-051775
2023-12-18
Form 8-K
ID: 0001193125-23-297097